RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study.

The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study.

Add to Collection
2021 May-Jun Observational studies J Chacko, S Dhandapani, V Jahagiridhar… - Indian Journal of …, 2021 - ncbi.nlm.nih.gov

Full Author : ['Chacko, Jithin', 'Dhandapani, Shankar', 'Jahagiridhar, Vidhya', 'Swaminathan, Krishnan']
Journal Title : Indian journal of pharmacology
Chapter : Section3
Journal Year : 2021
Cited by : 1.0

The aim of this study was to assess the short-term cardiometabolic outcomes in type 2 diabetes patients receiving empagliflozin in a tertiary referral center. Three hundred and fifteen consecutive patients started on empagliflozin were followed for a 4-mo..... Read More

Keywords : ["shortterm observational study", "cardiometabolic risk factor", "type diabetes", "patient", "empagliflozin", "effect"]
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262422/
Google Scholar Link : https://scholar.google.com/scholar?cites=5407821074783037302&as_sdt=8000005&sciodt=0,19&hl=en&num=20